The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
Though a short-term PR success, the company’s commitment risks looking hollow after its decision not to license know-how to new WHO Africa tech-transfer hub
15 October 2021
World-beating R&D and patent rates propel country to top of Asia for the first time in annual WIPO study, but Global Innovation Index also shows areas where IP professionals can help it improve further
27 September 2021
The WHO’s African vaccine hub is seeking to imitate the company’s jab, but an agreement has yet to be reached
24 September 2021
09 September 2021
The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force
03 September 2021
Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law
19 August 2021
$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field
12 August 2021
With text-based discussions of a TRIPS suspension about to get underway, IAM highlights the key issues to be aware of.
17 June 2021
A scheme premised on a rejection of the legitimacy of IP during a pandemic was never going to get the buy-in necessary to make it work
28 May 2021
White House backing for the covid vaccine IP waiver puts the pro-patent Delaware senator in a powerful position to decide who gets the job
25 May 2021
Unlock unlimited access to all IAM content
